期刊文献+

原发性开角型青光眼患者使用拉坦前列腺素前后24h眼压曲线比较 被引量:8

Compare 24-hour intraocular pressure curve in primary open-angle glaucoma patients before and after using latanoprost
原文传递
导出
摘要 目的通过观察原发性开角型青光眼(POAG)患者使用拉坦前列腺素前后24h眼压曲线的变化,评价其24h降眼压效果,为临床应用提供指导。方法回顾性分析2010年1月至2010年7月在首都医科大学附属北京同仁医院眼科中心接受24h眼压监测患者的病历,筛选出使用拉坦前列腺素进行初次治疗的POAC患者。比较在用药前后24h眼压曲线的变化。眼压测量使用回弹式眼压计,测量时间点为10:00、14:00、18:00、22:00、2:00、6:00和8:00。结果共有26例入选,其中男性12例,女性14例,平均年龄(49±15)岁。用药后不同时间点眼压降低的幅度在4.0-6.3mmHg,除2:00外,其余时间点用药前后的差别有统计学意义。用药前眼压的峰值、均值、24h波动值分别为(26.3±7.7)、(21.9±6_3)和(8.4±3.2)mmHg,用药后相应值分别为(21.7±5.6)、(16.9±4.0)和(8.4±4.1)mmHg,较用药前分别降低(4.6±3.8)mmHg(F=6.14,P=0.017)、(5.0±2.9)(F=11.33,P=0.001)和(0.1±4.3)mmHg(F=0.004,P=0.951)。结论除2:00点外,拉坦前列腺素在其他时间点均可明显降低眼压,24h眼压的峰值和均值亦有明显降低.但对眼压波动无明显影响。 Objective To evaluate the effect of latanoprost reducing the 24-hour intraocular pressure (lOP) and supply directions for clinical application, observing the change of 24-hour IOP in primary open-angle glaucoma (POAG) patients. Methods Retrospective analyzed the patients' case files who received the monitoring of 24-hour IOP in Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University from January to July, 2010. And those POAG patients who first received latanoprost therapy were selected. The differences of 24-hour IOP curve before and after medication were compared. Icare rebounder tonomer was used, the IOP were measured at 10 am, 2pm, 6pm, 10pm, 2am, 6am and 8am. Results The amplitude of lowering IOP after medication was 4.0-6.3mmHg in different time except for 2 am, there was a statistically significant difference before and after medication in other time. The peak, mean and 24-hour IOP were 26.3±7.7, 21.9±6.3, 8.4±3.2mmHg before medication, and 21.7±5.6, 16.9±4.0, 8.4±4.1mmHg after medication respectively. Separately reducing the IOP 4.6~3.8 (F =6.14,P =0.017), 5.0±2.9 (F =11.33, P =0.001) and 0.1~4.3mmHg (F =0.004, P =0.951). Conclusions Latanprost provide effective 24-hour IOP reduction except for 2 am. The peak and mean IOP are significantly reduced in 24-hour IOR However, latanoprost has no significantly effect for fluctuation of IOP.
出处 《中国实用眼科杂志》 CSCD 北大核心 2013年第2期150-153,共4页 Chinese Journal of Practical Ophthalmology
关键词 开角型青光眼 拉坦前列腺素 24h眼压 Open-angle glaucoma Latanoprost 24-hour intraocular pressure
  • 相关文献

参考文献20

  • 1梅丽克木.艾山,具尔提.哈德尔.多佐胺和噻吗洛尔联用与拉坦前列腺素比较治疗开角型青光眼的系统评价[J].中国循证医学杂志,2009,9(3):350-354. 被引量:7
  • 2王宁利,梁远波,乔利亚,李树宁,王洪涛,王华.拉坦前列腺素降眼压作用与小梁网房水排出途径的关系探讨[J].中华眼科杂志,2006,42(4):341-343. 被引量:23
  • 3王维光,李战梅,贺翔鸽.拉坦前列腺素对青光眼的降压效果[J].国际眼科杂志,2003,3(4):117-118. 被引量:2
  • 4Denis P,Baudouin C,Bron A. First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients:a 3-month efficacy analysis stratified by initial intraocular pressure[J].BMC Ophthalmology,2010.4.
  • 5Fristrom B,Uusitalo H. A randomized.36-month.post-market ing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension[J].Acta Ophthalmologica,2010,(01):37-43.
  • 6Johnson T V,Fan S,Zhan G. Efficacy and Mechanisms of Intraocular Pressure Reduction With Latanoprost and Timolol in Participants With Ocular Hypertension:A Comparison of 1 and 6 Weeks of Treatment[J].Glaucoma,2010,(06):356-364.
  • 7Dekking H M,Coster H D. Dynamic tonometry[J].Ophthalmologica.Journal International D'ophtalmologie.International Journal of Ophthalmology.Zeitschrift Fur Augenheilkunde,1967,(01):59-74.
  • 8Kontiola A. A new electromechanical method for measuring intraocular pressure[J].Documenta Ophthalmologica,1996,(03):265-276.
  • 9Kontiola AI,Goldblum D,Mittag T. The induction/impact tonometer:a new instrument to measure intraocular pressure in the rat[J].Experimental Eye research,2001.781-785.
  • 10Erdurmus M,Yagci R. Dynamic contour tonometer versus goldmann applanation tonometer[J].Journal of Glaucoma,2006,(05):471-473.

二级参考文献15

  • 1Y.H.ZOU,G.C.Y.Chiou.青光眼药物治疗的进展(英文)[J].国际眼科杂志,2005,5(3):411-422. 被引量:9
  • 2Bitch R,Ishikawa H,Rothman R,et al. The efficacy of Latanoprost is independent of the width of the ciliary body face. J Glaucoma,2002,11:239-243.
  • 3Saw SM, Gazzard G, Friedman DS. Interventions for angle-closure glaucoma: an evidence-based update. Ophthalmology, 2003, 110 :1869-1878.
  • 4Chew PT, Aung T, Aquino MV, et al. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma. Ophthalmology ,2004,111:427-434.
  • 5Aung T, Wong HT, Yip CC, et al. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.Ophthalmology,2000,107 : 1178-1183.
  • 6Orzalesi N, Rossetti L, Invemizzi T, et al. Effect of timolol,latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci ,2000,41:2566-2573.
  • 7Camras CB, Alm A, Watson PG. Latanoprost : a prostaglandin analog for glaucoma therapy. Ophthalmology, 1996,103 : 1916-1924.
  • 8Stamper RL, Lieberman MF, Drake MV. Becker-shaffer's diagnosis and therapy of the glaucomas. 7th ed. Singapore: Harcourt Asia,1999. 500.
  • 9Stamper RL, Lieberman MF, Drake MV. Becker-shaffer's diagnosis and therapy of the glaucomas. 7th ed. Singapore: Harcourt Asia,1999. 53.
  • 10Kook MS,Cho HS,Yang SJ,et al. Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face:a preliminary study. J Ocul Pharmacol Ther,2005, 21:75-84.

共引文献29

同被引文献71

  • 1金晓红,钱韶红,孙兴怀.0.03%贝美前列素滴眼液与0.005%拉坦前列素滴眼液的降眼压效果和安全性比较[J].中国实用眼科杂志,2005,23(7):712-714. 被引量:5
  • 2刘玉岭,高宁,陈玮,赵梅.吲哚美辛对拉坦前列腺素治疗慢性闭角型青光眼疗效的影响[J].中国实用眼科杂志,2006,24(7):700-702. 被引量:4
  • 3孔祥梅,孙兴怀,孟樊荣,钱韶红,金晓红,刘淳诗,茅凤英.三种前列腺素类药物降眼压效果比较[J].眼视光学杂志,2006,8(4):228-230. 被引量:19
  • 4张卫宏.原发性开角型青光眼的临床治疗效果观察[J].中国保健营养,2013,(6):41-42.
  • 5Hommer A, Kimmich F. Switching patient from preserved prostaglandin-analog monotherapy to preservative-free tafluprost [J]. Clinical Ophthalmology, 2011,5 : 623-631.
  • 6Sullivan-Mee M, Gerhardt G, Halverson KD, et al. Repeata- bility and reproducibility for intraocular pressure measure- ment by dynamic contour, ocular response analyzer,and goldmann applanation tonometry [J]. J Glaucoma,2009,18 (9) :666-673.
  • 7Chiselita D,Pentru E. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients [J]. Of- talmologia, 2007,51 (2) : 81-86.
  • 8Chiselita D, Pentru E. Evaluation of the role of travoprost0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients [J]. Of- talmologia, 2007,51 (2) : 81-86.
  • 9Fogagnolo P,Capizzi F,Orzalesi N,et al. Can mean cen- tral corneal thickness and its 24-hour fluctuation influ- ence fluctuation of intraocular pressure? [J]. J Glaucoma, 2010,19(6) :418-423.
  • 10Konstas AG,Mikropoulos D,Haidich AB,et al. Twenty-four- hour intraocular pressure control with the travoprost/tim- olo maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-an- gle glaucoma [J]. Br J Ophthalmol,2009,93(4):481-485.

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部